DK0733634T3 - Fremgangsmåde til fremstilling af et thieno(2,3-b) (1,5)benzodiazepinderivat - Google Patents

Fremgangsmåde til fremstilling af et thieno(2,3-b) (1,5)benzodiazepinderivat

Info

Publication number
DK0733634T3
DK0733634T3 DK96301999T DK96301999T DK0733634T3 DK 0733634 T3 DK0733634 T3 DK 0733634T3 DK 96301999 T DK96301999 T DK 96301999T DK 96301999 T DK96301999 T DK 96301999T DK 0733634 T3 DK0733634 T3 DK 0733634T3
Authority
DK
Denmark
Prior art keywords
thieno
preparation
benzodiazepine derivative
benzodiazepine
derivative
Prior art date
Application number
DK96301999T
Other languages
English (en)
Inventor
Charles Arthur Bunnell
David Edward Tupper
Terrence Michael Hotten
Samuel Dean Larsen
Barry Arnold Hendriksen
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27020696&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0733634(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/410,474 external-priority patent/US5631250A/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of DK0733634T3 publication Critical patent/DK0733634T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK96301999T 1995-03-24 1996-03-22 Fremgangsmåde til fremstilling af et thieno(2,3-b) (1,5)benzodiazepinderivat DK0733634T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40956695A 1995-03-24 1995-03-24
US08/410,474 US5631250A (en) 1995-03-24 1995-03-24 Process and solvate of 2-methyl-thieno-benzodiazepine

Publications (1)

Publication Number Publication Date
DK0733634T3 true DK0733634T3 (da) 2000-12-11

Family

ID=27020696

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96301999T DK0733634T3 (da) 1995-03-24 1996-03-22 Fremgangsmåde til fremstilling af et thieno(2,3-b) (1,5)benzodiazepinderivat

Country Status (17)

Country Link
EP (1) EP0733634B1 (da)
AR (2) AR002721A1 (da)
AT (1) ATE197711T1 (da)
AU (1) AU5257896A (da)
CO (1) CO4700300A1 (da)
DE (1) DE69611003T2 (da)
DK (1) DK0733634T3 (da)
EG (1) EG24221A (da)
ES (1) ES2151991T3 (da)
GR (1) GR3035355T3 (da)
IL (1) IL117613A (da)
MY (1) MY116503A (da)
PE (1) PE38197A1 (da)
PT (1) PT733634E (da)
SI (1) SI0733634T1 (da)
WO (1) WO1996030374A1 (da)
YU (1) YU49276B (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ334346A (en) 1996-09-23 2000-05-26 Lilly Co Eli Olanzapine dihydrate D comprising 2-methyl-4-(4-methyl-1-piperazinyl)-1OH-thieno[2,3-b][1,5]benzodiazepine and a formulation for use in treating central nervous system disorders
ZA978515B (en) * 1996-09-23 1999-03-23 Lilly Co Eli Intermediates and process for preparing olanzapine
FR2802101B1 (fr) 1999-12-10 2003-02-28 Aventis Pharma Sa Association de cymemazine et d'un neuroleptique atypique
AU2003237305A1 (en) 2002-05-31 2003-12-19 Geneva Pharmaceuticals, Inc. Process of preparation of olanzapine form i
SI21270A (sl) 2002-07-15 2004-02-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Kristalne oblike olanzapina in postopki za njihovo pripravo
AU2003300324A1 (en) 2002-12-24 2004-07-22 Teva Pharmaceutical Industries Ltd. Novel crystal forms of olanzapine, methods for their preparation and method for the preparation of known olanzapine crystal forms
ATE397611T1 (de) 2003-12-22 2008-06-15 Teva Pharma Verfahren zur herstellung von olanzapin
US20070072845A1 (en) * 2004-02-19 2007-03-29 Davuluri Rammohan Rao Process for the preparation of olanzapine form 1 useful as antipsychotic drug
ES2253091B1 (es) * 2004-07-27 2007-02-01 Inke, S.A. Solvato mixto de olanzapina, procedimiento para su obtencion y procedimiento de obtencion de la forma i de olanzapina a partir del mismo.
PL1838716T3 (pl) 2005-01-05 2011-09-30 Lilly Co Eli Dihydrat embonianu olanzapiny
CA2593407A1 (en) * 2007-06-22 2008-12-22 Apotex Pharmachem Inc. Improved processes for the synthesis of olanzapine
CU20090172A6 (es) 2009-10-09 2011-10-05 Facultad De Quimica Universidad De La Habana Sistemas tricíclicos y tetracíclicos con actividad sobre el sistema nervioso central y vascular
EP2486913A1 (en) 2011-02-14 2012-08-15 Labtec GmbH Rapidly disintegrating oral film formulation for Olanzapin

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4237279A (en) * 1979-07-27 1980-12-02 Eli Lilly And Company Crystalline 3-hydroxycephalosporin solvates
GB9009229D0 (en) * 1990-04-25 1990-06-20 Lilly Industries Ltd Pharmaceutical compounds
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
NO305125B1 (no) * 1992-05-29 1999-04-06 Lilly Industries Ltd Farmas°ytiske forbindelser
US5439888A (en) * 1994-03-04 1995-08-08 Eli Lilly And Company Antithrombotic agents
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use

Also Published As

Publication number Publication date
IL117613A0 (en) 1996-07-23
AU5257896A (en) 1996-10-16
AR002721A1 (es) 1998-04-29
SI0733634T1 (en) 2001-06-30
PT733634E (pt) 2001-04-30
DE69611003D1 (de) 2000-12-28
EG24221A (en) 2008-11-10
YU49276B (sh) 2005-03-15
AR004169A1 (es) 1998-11-04
ES2151991T3 (es) 2001-01-16
EP0733634B1 (en) 2000-11-22
WO1996030374A1 (en) 1996-10-03
YU17696A (sh) 1998-07-10
PE38197A1 (es) 1997-10-16
GR3035355T3 (en) 2001-05-31
MY116503A (en) 2004-02-28
EP0733634A1 (en) 1996-09-25
IL117613A (en) 2000-07-16
ATE197711T1 (de) 2000-12-15
DE69611003T2 (de) 2001-05-10
CO4700300A1 (es) 1998-12-29

Similar Documents

Publication Publication Date Title
DK0733635T3 (da) Krystalformer af et thieno[2,3-b] [1,5]benzodiazepin-derivat og fremgangsmåde til deres fremstilling
DK0770615T3 (da) Fremgangsmåde til fremstilling af dihalogenazolopyrimidiner
IS4148A (is) Hliðstæð aðferð til framleiðslu á 1,5 Benzodiazepine afleiðum
DK0812357T3 (da) Fremgangsmåde til fremstilling af heteromultimere polypeptider
IS3970A (is) Hliðstæð aðferð til framleiðslu á 1,5-benzódíazepín afleiðum
DK0828601T3 (da) Fremgangsmåde til fremstilling af rørformede, varmegenoprettelige genstande
NO981800D0 (no) FremgangsmÕte for fremstilling av 1,1,1,3,3-pentafluorpentan
DK0905254T3 (da) Fremgangsmåde til fremstilling af en lavemolekylær
DK0733634T3 (da) Fremgangsmåde til fremstilling af et thieno(2,3-b) (1,5)benzodiazepinderivat
NO974169D0 (no) Fremgangsmåte for tetra-azacykloalkan-fremstilling
DK0768310T3 (da) Fremgangsmåde til fremstilling af imidazo-benzodiazepin-derivater
DK0877738T3 (da) Fremgangsmåde til fremstilling af phenylimidazolidinderivater
DK0839138T3 (da) Fremgangsmåde til fremstilling af N-substituerede 3-hydroxypyrazoler
DK0927195T3 (da) Fremgangsmåde til fremstilling af et plasmaproteinholdigt lægemiddel
DK0721453T3 (da) Fremgangsmåde til fremstilling af N-methyl-3-(1-methyl-4-piperidinyl)-14-indol-5-ethansulfonamid
DK0815092T3 (da) Fremgangsmåde til fremstilling af 1,2-benzisothiazolin-3-oner
FI973644A0 (fi) Uusi menetelmä 2,3-dihydrobentsofuranolijohdannaisten valmistamiseksi
NZ326039A (en) Process for making 3,4-dihydro-pyrimidin-2(1h)-one derivatives
DK0735043T3 (da) Fremgangsmåde til fremstilling af 2-substitueret 3,3-difluorfuran
DK0721929T3 (da) Fremgangsmåde til fremstilling af hydroxyalkoxybenzophenoner
DK0876333T3 (da) Fremgangsmåde til fremstilling af pesticider
DK0863874T3 (da) Fremgangsmåde til fremstilling af dioxoazabicyclohexaner
DK0787729T3 (da) Fremgangsmåde til fremstilling af imidazodiazepinderivater
NO995750D0 (no) Fremgangsmåte til fremstilling av et deoksyuridinderivat
DK0729959T3 (da) Fremgangsmåde til fremstilling af loracarbefmonohydrat